NCT05451563 Double-S: a Wearable Device for Erectile Dysfunction
| NCT ID | NCT05451563 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Erectile Dysfunction |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2024-03-21 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2024-03-21 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to use a minimally invasive erectile device for patients suffering from erectile dysfunction.
Eligibility Criteria
Inclusion Criteria: * males \>18 years old suffering from any cause moderate to severe erectile dysfunction (e.g. ED after radical prostatectomy and/or radiation therapy for prostate cancer and or other pelvic malignancies affecting the sexual potency; emotional and psychological ED; organic vascular and/or metabolic ED etc.) * having a female partner willing to participate in the study Exclusion Criteria: * not willing to attempt sexual vaginal intercourse with their partner * inability to wear/operate the external penile device for any reason
Contact & Investigator
Michael Eisenberg, MD
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT05451563 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Erectile Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05451563 currently recruiting?
Yes, NCT05451563 is actively recruiting participants. Contact the research team at sbasran@stanford.edu for enrollment information.
Where is the NCT05451563 trial being conducted?
This trial is being conducted at Stanford, United States.
Who is sponsoring the NCT05451563 clinical trial?
NCT05451563 is sponsored by Stanford University. The principal investigator is Michael Eisenberg, MD at Stanford University. The trial plans to enroll 10 participants.